Cargando…

(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments

In life-threatening conditions such as cancer and rare diseases, where there is no cure and no U.S. Food and Drug Administration (FDA)-approved therapy, patients sometimes seek access to an unapproved, experimental therapy through expanded access programs as their last, best hope for treatment to sa...

Descripción completa

Detalles Bibliográficos
Autor principal: Hogan, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772317/
https://www.ncbi.nlm.nih.gov/pubmed/26926908
http://dx.doi.org/10.1186/s12916-016-0586-6